BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details 2) - shares		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019
Anti-dilutive securities		4,981,717	427,545
Series A & B Preferred Stock [Member]
Anti-dilutive securities		2,232	2,232
Stock Option [Member]
Anti-dilutive securities		950	2,906
Warrant [Member]
Anti-dilutive securities	[1]	3,582,116	72,921
Convertible Notes [Member]
Anti-dilutive securities		1,396,419	349,486

[1] The Company has excluded 6,500 warrants issued in April 2019, which may be exercised by means of a cashless exercise into 6,500 shares of the Companys common stock, in its anti-dilutive securities but included the warrants in its weighted average shares outstanding.